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It has been nearly twenty years since our security market had been established. 
the market has been invalid from the previous to the current development of the 
market was generally recognized by scholars of the weak-form efficient market, 
but China's securities market is a relatively young market, the majority of 
individual investors hasn’t know the true value of the company, therefore, how to 
measure the value of listed companies for investors from a different perspective to 
make risk prompted the development of China's capital market is an important issue. 
At the same time, the successful of China's share reform announcement that the 
stock market has been into the full circulation times, and at this moment a large 
number of the academic and theoretical circles take concerned about the problem of 
market value management issues, the state-owned Assets Supervision and 
Administration Commission has also formally included this index to evaluate the 
performance. Therefore, how to improve the company's market value is of a great 
significance. 
It is nature for us to evaluate the company's market value once we concerned 
about the  company's value. Therefore this paper is about the investment value 
analysis of stock. With a wide range of all available public information, we have 
adopted professional analysis methods and analysis techniques to integrated analysis. 
Pharmaceutical industry is recognized one of the world’s never the decline of the 
sunrise industry, and pharmaceutical and healthcare industry is the fastest growing 
sub-sectors industry, the Dong-E  E-jiao Co., Ltd. is the leader in health care industry, 
so we choose it for analysis. Specifically, we analyzed the trend of China's 
macro-economic as well as the pharmaceutical industry's future development trends, 
predict their impact on the Dong-E E-jiao Co., Ltd. So we use Porter's five forces 
model to analysis the major industry of the company. While analyzing the background, 
we focus on the company's financial situation, by comparing the company's operating 
ability, solvency and other issues. Finally, we predict the future development of the 













equity cash flow discounted model to assess the value of the business. For the 
evaluate of the conclusions of the assessment, we also take a widely used method 
called the Monte Carlo simulation technology for the valuation of the risk, we found 
the change of the cost of equity affect the stock value mostly. During the analyzing, 
we conclude the investment risk for the investors. At the end, we give advises to the 
listed companies managers on how to do a good job to upgrade the market value of 
the company. 
Investing on the value stocks is the subject of common concern for all investors, 
through the value analysis of Dong-E E-jiao Co., Ltd, we can conclude that the 
company behaves excellent in the operation and the company’s ability to pay and so 
on .The stock of this company has also less risks and less sensitivity to the 
macro-economic impact. It can resist to the role of stock market volatility, and it is a 
good value investment stock. 
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由国有企业改制为股份制企业。1996 年成为上市公司，同年 7 月 29 日“东阿阿
胶”A 股股票在深交所挂牌上市，公司连续 7 年入围“中国 具发展力的上市公司
50 强”。 
东阿阿胶股份有限公司是我国国内 大的阿胶及系列产品生产企业，公司注
册资本 139,730,556 元，2000 年 8 月公司经配股及转增股本后增至 209,595,667
股，2001 年 4 月 15 日经股东大会批准以资本公积每 10 股转增 3 股后股本增至
272,474,366。2004 年 4 月 29 日经股东大会批准以 2003 年末总股本 272,474,366
股为基数，向全体股东每 10股送 2股以资本公积转增 3股后股本增至 408,711,549
股。2007 年 5 月 15 日召开的股东大会审议通过了用资本公积金向全体流通股股
东每 10 股转增股本 4 股的股权分置改革方案，公司的总股份从 408,711,549 股增
至 523,763,614 股。 
东阿阿胶股份有限公司下辖一个核心公司，17 个控股子公司，现有员工 4700




畅销全国 28 年，累计销量超过 120 亿支。 
2．2 东阿阿胶股份有限公司股东构成 
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